The global contrast injector systems market revenue was around US$ 896.9 million in 2022 and is estimated to reach US$ 1,690.9 million by 2031, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period from 2023 to 2031.
A contrast injector system is a medical diagnostic device that makes utilize of a contrast media to make visual pictures of the interior of the human body to monitor, diagnose, or treat clinical disorders. The key imaging process includes magnetic resonance imaging, computed tomography, and angiography. The contrast injector improves the contrast structures or fluids visibility within the body as compared to conventional image processing.
Market Driving Factors
Government investments in healthcare infrastructure drive the market growth. Government funding for diagnostic imaging services is sufficient and is increasing rapidly annually due to the expanding usage of diagnostic imaging in the fields of radiology and image-guided minimally invasive surgery.
The prevalence of cancer with cardiovascular disease (CVD) creates a positive impact on the market. Over the past few decades, there has been a significant increase in the number of cancer patients. Strokes and cardiovascular disease also cause the majority of deaths worldwide. In addition, contrast injectors inject radio-opaque contrast material into the patient's body to enhance the safety and image quality during diagnostic imaging. Furthermore, contrast injectors are estimated to benefit from a surge in the number of cardiovascular and cancer disease patients, which will lead to an increase in demand for upgraded healthcare facilities and cutting-edge diagnostic imaging methods.
High prices and risks associated with contrast injector systems are expected to hamper market growth.
Regional Analysis
North America dominated the market and is expected to continue its dominance over the forecast period. This can be attributed to the research activities for contrast injector systems, recent technological advancements, well-established healthcare facilities, and an increase in demand for early diagnosis of chronic diseases owing to a surge in awareness regarding contrast injectors.
Asia-Pacific is estimated to register the highest rate in the market. This is due to the surge in the incidence of people suffering from several chronic diseases, such as heart disease, cancer, dementia, and Alzheimer’s, and the increase in the ageing population.
Segmentation Insights
Product Type Insight
The injector system is estimated to dominate the market. This is due to the increase in the incidence of chronic ailments such as several types of Alzheimer’s, cancer, dementia, and other diseases, which is predicted to create a demand for diagnostic procedures for precise treatment.
Application Insight
The interventional radiology segment dominates the market in terms of the largest shares. This is because of decreased risks, less cost, a higher level of comfort, faster recovery, and shorter hospital stays. Additionally, various diagnostic procedures that can be performed utilizing interventional radiology include, cholangiography, angiography, and biopsy.
End User Insight
The hospital segment dominates the market in terms of the growth rate. This is due to the adoption of the latest imaging technologies at the earliest to provide effective analysis of functional areas, which were not visible by conventional or older technologies.
Prominent Companies
Segmentation Outline
The global contrast injector systems market segmentation focuses on Product Type, Application, End User, and Region.
By Product Type
By Application
By End User
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL CONTRAST INJECTOR SYSTEMS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: CONTRAST INJECTOR SYSTEMS MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL CONTRAST INJECTOR SYSTEMS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE
5.1 OVERVIEW
5.2 CONSUMABLES
5.3 INJECTOR SYSTEMS
5.4 ACCESSORIES
6 GLOBAL CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 RADIOLOGY
6.3 INTERVENTIONAL RADIOLOGY
6.4 INTERVENTIONAL CARDIOLOGY
7 GLOBAL CONTRAST INJECTOR SYSTEMS MARKET, BY END USER
7.1 OVERVIEW
7.2 DIAGNOSTICS CENTERS
7.3 CLINICS
7.4 HOSPITALS
7.5 OTHERS
8 GLOBAL CONTRAST INJECTOR SYSTEMS MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3.1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL CONTRAST INJECTOR SYSTEMS MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
9.4 COMPETITIVE DASHBOARD
9.5 PRODUCT MAPPING
9.6 TOP PLAYER POSITIONING, 2022
9.7 COMPETITIVE HEATMAP
9.8 TOP WINNING STRATEGIES
10 COMPANY PROFILES
10.1 BRACCO IMAGING S.P.A
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.2 ULRICH GMBH & CO. KG
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.3 GUERBET GROUP
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.4 SINO MEDICAL- DEVICE TECHNOLOGY CO LTD
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.5 NEMOTO KYORINDO CO. LTD
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.6 BAYER HEALTHCARE LLC
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.7 GE HEALTHCARE
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.8 MEDTRON AG
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.9 VIVID IMAGING
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.10 SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved